Connect with us

News

The world’s first CBD facial comes to the UK

Published

on

As the world’s first industry-endorsed CBD facial and cosmeceutical skincare range launches in the UK, Cannabis Health speaks to those behind it.

Now widely recognised for its anti-inflammatory and antioxidant properties, cannabis is changing the face of the beauty industry.

As the latest go-to ingredient for skin and beauty brands, an influx of CBD-infused products have hit the shelves in recent years, with an industry report published earlier this year suggesting that the CBD skincare market is projected to generate £734m in annual sales by 2024.

Meanwhile leading doctors have touted the potential of cannabis to treat rare and challenging skin conditions, such as atopic eczema, allergic contact dermatitis and psoriasis, as the UK’s first medical cannabis dermatology service launched at the Sapphire Clinic in London in September.

But until now, no one has brought the two together.

The Grass Roots Facial, the world’s first CIBTAC (Confederation of International Beauty Therapy and Cosmetology) endorsed CBD facial procedure – using a full range of cosmeceutical CBD skincare products – is coming to the UK from October.

Created by global beauty training provider SkinTres, founders Jo Minchin, Lyndsey Price and Zoe Wilkinson saw the potential of the cannabinoid and set out to create a dynamic, results-driven and relaxing facial – but quickly realised that they would need to develop their own skincare range too.

SkinTres founders (from left) Lyndsey Price, Jo Minchin and Zoe Wilkinson

“Other brands were doing a nod to CBD, with products containing 100mg or less, but nobody was doing the cosmeceutical skincare that most women in their 30s and 40s now are using,” said Jo Minchin, co-founder of SkinTres, Grass Roots Facial and Grass Roots Skin.

“If you wanted to incorporate CBD into your skincare, you’d have to buy a CBD oil and use this alongside your existing skincare routine –  it was adding too much and is also quite expensive.”

She added: “We saw this gap in the market and it felt like a perfect opportunity to incorporate CBD into our own range of cosmeceutical skincare, along with retinols, Vitamin C and hyaluronic acid.”

There are initially seven products in the Grass Roots Skin range from the AHA Cleansing Wash and AHA Skin Tonic at £28.99, to the Skin Drench Super Serum, containing 15 percent vitamin C, hyaluronic acid and 300mg of CBD isolate – which at £54.99 has been described as the brand’s ‘superhero’.

Also in the range are a 1% Retinol Repair Cream, Retinol Eye Refiner, Super Glow Miracle Oil and Super Shield SPF50, all of which have been third party tested, are vegan-friendly, cruelty-free and unisex.

The products go hand in hand with the Grass Roots Facial, a five step, in-salon treatment which can be personalised to suit any skin type and is designed to give instant results.

It starts with dermaplaning, where a fine surgical blade is passed back and forth along the top layer of the skin to remove dead skin cells and allows the skin to absorb the ingredients of the products.

A special CBD-infused oil is used to boost the anti-inflammatory effect of lymphatic drainage, a therapeutic massage treatment, which uses light pressure and rhythmic strokes to increase the flow of lymph and reduce toxins in the body.

LED light therapy then uses different wavelengths of light to target certain conditions including acne, rosacea, sensitive, pigmented and ageing skin.

“We’ve designed the facial so that anyone can benefit from it, by creating different processes within it that can be adapted for any skin condition,” explained co-founder Zoe Wilkinson from the Skin Tres salon and training centre in Oxfordshire.

“For example, if someone has active acne we wouldn’t do the dermaplaning part of the facial, but we could do more lymphatic drainage and spend more time with the LED light.

“The idea is that the skin will absorb the products better and the end result will be an instant glow, as well as reducing inflammation and redness, but also a really relaxing facial.”

At the moment the Grass Roots Facial and skincare range will only be available at salons where therapists have completed a Skin Tres CIBTAC approved course.

From October 2020 training will be provided at the SkinTres training centres in Witney in Oxfordshire and Marple in Cheshire, but the aim is to roll it out to salons across the UK.

“An important part of our message is educating people about CBD, so a big part of the process is training and teaching therapists to be knowledgeable about the products, so they can teach their clients the benefits of that and help to educate people,” said Jo.

“A lot of people are still afraid of CBD and don’t really understand it, but the more we people can educate about it, the more people will try it.

“In five years, everybody will have probably tried something with a bit of CBD in.”

And this could be groundbreaking in how common skin conditions are managed.

Zoe added: “The biggest use for CBD is in skin conditions such as eczema, acne and psoriasis, because of its anti-inflammatory and antibacterial properties.

“Doctors often prescribe strong ointments for these conditions, so if people can treat them with something natural like CBD, before going down the medical route, that could massively change how we use skincare.”

For more information visit www.grassrootsskin.com and www.skintres.com

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published.

Advocacy

Fair Trials and Last Prisoner Project seek to launch global cannabis justice project

Fair Trials’ Global CEO Norman L. Reimer to discuss the project at Cannabis Europa Conference in London on June 29.

Published

on

fair trials cannabis justice

A new initiative from Fair Trials and the Last Prisoner Project aims to redress the harm caused by cannabis prohibition and to secure relief for those in prison for cannabis-related convictions.

The criminal justice reform NGO, Fair Trials hopes that the industry will support its work in countries across the globe where cannabis laws are being liberalised. Through collaboration with local partners in appropriate jurisdictions, the Fair Trials project will identify people in need of legal assistance, and recruit, train and match volunteer lawyers to take on their cases.

Fair Trials has enlisted the help of the Last Prisoner Project, a coalition of cannabis industry leaders, executives and artists dedicated to bringing restorative justice to the cannabis sector.

More and more jurisdictions are allowing adults to use and distribute medical and recreational cannabis. But after decades of prohibition, countless people remain behind bars or continue to suffer the collateral consequences of a cannabis conviction.

US research programme studies cannabinoids in ovarian cancer

“The injustice of cannabis prohibition has resulted in millions of people worldwide serving time in prison or being saddled with a cannabis conviction, which brings with it a lifetime of harmful consequences, ranging from education and employment opportunities to immigration status and parental rights,” said Fair Trials Global CEO, Norman L Reimer.

“Of course, these harmful effects of prohibition not only impact the individuals charged, but also their families and communities. And those effects have been borne disproportionately by minorities, communities of colour, and the socio-economically disadvantaged. Legalising cannabis alone does not equal justice. Together, we must address the ongoing harms of past prohibition and leave no cannabis prisoner behind.”

The project will be modelled on the US Cannabis Justice Initiative, a collaborative effort between the cannabis industry and volunteer lawyers in the United States. When Norman Reimer was the Executive Director of the National Association of Criminal Defense Lawyers (NACDL), he partnered with the Last Prisoner Project to establish the initiative.

“Key to the success of the initiative has been generous donations from legal cannabis companies and consumers nationwide,” said Last Prisoner Project Co-Founder Steve DeAngelo. “Fair Trials, with its global reach as the world’s criminal justice watchdog, is uniquely positioned to build and house the infrastructure that’s going to be needed.”

Tomorrow (29 June), Norman Reimer will address the Cannabis Europa Conference discussing the project. Mr Reimer will be part of a panel entitled ‘Leave No Cannabis Prisoner Behind,’ and will be joined on that panel by Mary Bailey, Managing Director at the Last Prisoner Project; Dr. Laura Garius, Policy Lead at Release; and Denzel Uba, an individual impacted by criminal cannabis prohibition.

Continue Reading

Advocacy

TOWIE star Amy Childs launches CBD range in honour of Jorja Foundation

The product range sees a portion of the proceeds going to the Jorja Foundation.

Published

on

Amy Childs at the launch of her new CBD range, Jorja Botanicals

TOWIE star Amy Childs launched her new CBD range this week, with a star-studded event that shone a spotlight on the story of six-year-old Jorja Emerson.

Amy Childs was joined by former Love Islanders, Amy Hart and Cara Delahoyde-Massey, alongside her  co-stars, Frankie Essex, Tom Skinner, Carina Lepore, Saffron Lempriere and Mark Ferris, for a heart-warming event celebrating the launch of her new CBD Infused beauty range, Jorja Botanicals.

The signature collection sees a portion of the proceeds going to the Jorja Foundation, which was set up in honour of six-year-old medical cannabis patient, Jorja Emerson.

The event saw The Only Way Is Essex star Frankie Essex, break down in tears as she heard Jorja’s story. Frankie, who gave birth to twins four weeks ago, wiped her eyes when Robin Emerson, Jorja’s father, showed videos of the life-threatening seizures his daughter was suffering before they discovered medical cannabis

Love Island star, Amy Hart has since taken to Instagram to spread the word about the latest political campaign that sees Childs and Emerson petitioning to make medical cannabis more widely available on the NHS

The Jorja Botanicals range was inspired by Jorja, who was diagnosed with a rare chromosome abnormality called 1q43q44 deletion, which has a side effect of life-threatening seizures. Her illness resulted in her being admitted to intensive care on two separate occasions, where Robin was told that she may not make it.

jorja botanicals

TOWIE stars joined Amy Childs for the launch of her new CBD range

To save his daughter’s life, Emerson knew that he had to dig deep and find a treatment that would not only help Jorja but ultimately go on to help others.

At the time it was still illegal to prescribe cannabis in the UK. Emerson joined the campaign to see medical cannabis legalised in the UK in November 2018, and Jorja’s was among the first children to be legally prescribed medicinal cannabis.

In 2021 he went on to create the Jorja Foundation – a charity set up to help other families and children going through the same battles that Robin had to face.

The Jorja Foundation’s core principles are to fund special needs equipment that is not funded through the health system, fund family counselling, private appointments and tests when a second opinion is needed, as well s cannabis-based treatment for children in the UK and to continue to campaign and educate for wider NHS access in the UK for cannabis-based medications.  

Childs commented: “When I saw Robin & Jorja’s story on social media it broke my heart.

As a mum, I couldn’t imagine the pain of being told to take my child home to say goodbye to them. I love that Robin has fought for Jorja & is now helping other families with the Jorja Foundation. 

“I’m so happy that I can help the foundation by being the Creative Director of Jorja Botanicals. We have created some beautiful products for the whole family to enjoy. We will be donating a percentage of the proceeds to the foundation so that we can help as many families as possible. ”

 Emerson added: “ This is the fruition of a lot of hard work over many months and I am extremely proud to launch what is the first family brand in this category. In the coming weeks, we will also be launching a ‘parent’ focused cosmetic range in partnership with our creative director Amy Childs and our premium line of tincture oils.”

 

Home » News » The world’s first CBD facial comes to the UK

Continue Reading

News

South Africa launches first trial of cannabis for chronic pain

The study will test whether cannabis can replace opioids in the management of chronic pain.

Published

on

south africa cannabis trial

South Africa’s first cannabis trial has launched after initial results “show promise” for the treatment as a replacement for opioids.

The Pharma Ethics Observational Study is led by Biodata, a subsidiary of Labat Africa, and will test whether cannabis can replace opioids in the management of chronic pain.

The study will involve 1,000 participants who have been taking opioids for pain management for at least three months and are prepared to switch to cannabis as an alternative.

Biodata is the brainchild of Dr Shiksha Gallow, a cannabis clinician and the principal investigator in the trial which took over 18 months to get official clearance.

US research programme studies cannabinoids in ovarian cancer

Dr Gallow said the trial is set to be ground-breaking as South Africa’s first real-world study of medical cannabis. Researchers predict that it will provide much-needed insight into the link between cannabis genetics and patient outcomes.

Dr Gallow told Cannabiz Africa: “We are currently recruiting patients, and data-capturing all the questionnaires and feedback from the patients for the live Study. It has been fairly slow. However, more options have been introduced, as suggested by the patients in the pilot study.

“The pilot results of the study were very promising, as it showed 98 per cent of the patients have some sort of pain relief from the cannabis.

“We were able to wean these patients off their opioid treatment. In the pilot group of patients below the age of 55, it was shown this group preferred to smoke cannabis and patients older than 55 years preferred oil. The patients who smoked the cannabis had relief almost immediately, while the oil took some time to alleviate their pain.”

“Once we reach the sample size required and all of the relevant data has been collated, the results of the study will be published. We have currently renewed this study for another year, due to the initial slow uptake of research participants.”

Patients can apply to be research participants through the Biodata website.

Labat is expanding its footprint over the next few months with the introduction of CannAfrica kiosks in major shopping malls.

The company believes these will be the “ideal locations for physical sign-up points for the study”.

Labat said the kiosks will also serve as Biodata dispensaries and is engaging with a number of vape stores to do the same, although these would have to be subject to South African Health Products Regulatory Authority’s pharma-ethics requirements.

Home » News » The world’s first CBD facial comes to the UK

Continue Reading

Trending